|
 |
Hematological malignancyThis page contains recent news articles, when available, and an overview of Hematological malignancy but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.News: Hematological malignancy Nature.comHairy cell leukemia is a rare indolent lymphoproliferative malignancy characterized by splenomegaly and pancytopenia. Patients are prone to acquire ... Lymphoma in a patient with systemic lupus erythematosus - Mar 17, 2006 Nature.comA biopsy and tissue diagnosis are essential to confirm a diagnosis of hematological malignancy; a diagnosis can sometimes be made by assessment of an ... The clinical impact of antibacterial prophylaxis and cycling antibioti... - Feb 26, 2007 Nature.comA total of 543 patients were admitted to the hematological malignancy and ... Patients undergoing treatment for hematological malignancy and HSC transplant ... … irradiation + HD chemotherapy treats hematological malignancy - Mar 21, 2005 Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones..."The objective of this study was to evaluate the clinical outcome of the treatment of hematologic malignancies with alternate hemibody irradiation (AHBI) ... … irradiation + HD chemotherapy treats hematological malignancy - Mar 25, 2005 Pay-Per-View - Angiogenesis Weekly - Factiva, from Dow Jones..."The objective of this study was to evaluate the clinical outcome of the treatment of hematologic malignancies with alternate hemibody irradiation (AHBI) ... EBV reactivation and post transplant lymphoproliferative disorders … - Jun 2, 2008 Nature.com...of the EBV-associated disorder, but three patients died due to other causes such as severe aGVHD or relapse of the underlying hematological malignancy. ... … prophylaxis effective in neutropenia with hematological malignancy - Nov 1, 2005 Pay-Per-View - Life Science Weekly - Factiva, from Dow JonesKeywords: Bonn, Germany, Antifungal Prophylaxis, Itraconazole, Hematological Malignancy, Neutropenia, Safety & Efficacy. This article was prepared by Life ... Pancreatic atrophy is associated with gastrointestinal chronic GVHD … - Jul 20, 2009 Nature.comDespite a curative treatment for hematological malignancy, allo-SCT is associated with many adverse effects in recipients. Weight loss occurs in 20–30% of ... Extracorporeal photochemotherapy as second- or first-line therapy of ... - Nov 9, 2009 Nature.comFrom January 2001 to June 2008, 42 children with hematological malignancy received myeloablative-conditioned allogeneic BM transplants. ... … irradiation + HD chemotherapy treats hematological malignancy - Mar 27, 2005 Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones..."The objective of this study was to evaluate the clinical outcome of the treatment of hematologic malignancies with alternate hemibody irradiation (AHBI) ... Is BAL useful in patients with acute myeloid leukemia admitted in ICU... - Apr 24, 2008 Nature.comIn patients with hematological malignancy (HM) developing acute respiratory failure ... HM, hematological malignancy; ARF, acute respiratory failure; AML, ... Compound heterozygosity for two MSH6 mutations in a patient with... - Aug 15, 2005 Nature.comIn contrast to both these and the majority of the other reported cases of biallelic MMR gene mutations, our patient had no hematological malignancy or brain ... Biogen Idec Inc. at Leerink Swann Cancer Medicines Conference - Final. - Sep 18, 2006 Free with registration - Fair Disclosure Wire - AccessMyLibrary.comFirst of all, there's a history in the merged company of real expertise, experience long-standing strength in the area of hematological malignancy. ... Two PMS2 Mutations in a Turcot Syndrome Family with Small Bowel … - Mar 21, 2005 Nature.comMLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 1999;59: 290–293. | PubMed | ISI | ChemPort | ... Skin lesions mimicking septic arthritis.(PHOTO ROUNDS) - Oct 1, 2006 Pay-Per-View - Journal of Family Practice - Factiva, from Dow JonesMost commonly associated with hematological malignancy. Vegetative. Chronic, nonpainful superficial ulcer. * Treatment: Topical vs systemic ... A unifying strategy for clinical trials in rare urological malignancy - Sep 26, 2008 Nature.comThe answer might seem self-evident, but we know from our colleagues who deal with sarcoma, hematological malignancy and childhood cancer that it is possible ... Skin lesions mimicking septic arthritis.(PHOTO ROUNDS) - Oct 1, 2006 $4.95 - Journal of Family Practice - ECNextMost commonly associated with hematological malignancy. Vegetative. Chronic, nonpainful superficial ulcer. * Treatment: Topical vs systemic ... Amgen Presents Data From First Nplate(R) Study in Children With … - Dec 7, 2009 Forbes...of response to Nplate, and hematological malignancies and progression of malignancy in patients with a pre-existing hematological malignancy or MDS. ... MarketResearch.com: "Pipeline Insight: Hematological malignancies - … - May 5, 2005 $4.95 - M2 Presswire - ECNextOverview of hematological malignancy market including patient ... Understand unmet needs in the hematological malignancy market based on opinion leader ... Donor leukocyte infusions to treat hematologic malignancy relapse … - May 19, 2008 Nature.comBetween July 1991 and December 1999, 49 patients less than 18 years at the time of hematological malignancy diagnosis received DLI from their original HSCT ... Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards - Nov 23, 2009 MarketWatch...of response to Nplate, and hematological malignancies and progression of malignancy in patients with a pre-existing hematological malignancy or MDS. ... Rituximab treatment for a patient with type I cryoglobulinemic … - Dec 11, 2007 Nature.comFor example, if a patient has a hematological malignancy associated with cryoglobulinemia and renal disease, the patient's renal function will improve once ... MicroRNA expression in lymphocyte development and malignancy - Jan 10, 2008 Nature.comThere is rapidly accumulating evidence to suggest that dysfunctional expression of microRNAs is a common feature of hematological malignancy. ... Hematopoietic stem cell transplantation in childhood inherited bone … - Dec 17, 2007 Nature.comAcute myeloid leukemia is the most common hematological malignancy, and squamous cell carcinomas of the esophagus, head and neck, and urogenital tract are ... Amgen Highlights Data to be Presented at ASH - Nov 30, 2009 FOXBusiness...of response to Nplate, and hematological malignancies and progression of malignancy in patients with a pre-existing hematological malignancy or MDS. ... Centennial Medical Center plans $150M expansion - Oct 22, 2007 Bizjournals.comIt will have units for bone and marrow transplantation, hematological malignancy, medical oncology and surgical oncology. In September, Centennial announced ... Millennium reports promising results for blood cancer drug - Mar 13, 2008 Boston GlobeMultiple myeloma is common hematological malignancy. In the United States, more than 55000 people, many of them elderly, have the disease, and about 20000 ... Neighboring adipocytes participate in the bone marrow microenvironment... - Mar 22, 2007 Nature.comMultiple myeloma (MM) is a hematological malignancy, characterized by the accumulation of monoclonal plasma cells in the bone marrow (BM). ... Impaired activating receptor expression pattern in natural killer... - Jan 26, 2006 Nature.comMultiple myeloma (MM) is a hematological malignancy characterized by accumulation in the bone marrow of plasma cells that secrete a monoclonal ... Mannose-binding lectin levels and infections in children after... - Jul 13, 2009 Nature.comIn patients with a hematological malignancy receiving chemotherapy, increased susceptibility to infection and prolonged duration of febrile neutropenic ... A genome-wide association study identifies six susceptibility loci... - Aug 31, 2008 Nature.comThese data provide the first evidence for the existence of common, low-penetrance susceptibility to a hematological malignancy and new insights into disease ... Conditioning with fludarabine alone and allogeneic transplantation as... - Nov 20, 2006 Nature.comThe role of prophylactic DLI incorporated in the setting of NST for advanced hematological malignancy in selected groups of patients could be of interest ... Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1–69 - Jun 28, 2007 Nature.comGender plays an important role in the incidence, progression and prognosis of individuals with several forms of hematological malignancy. ... A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma/ … - Nov 10, 2005 Nature.com6 The majority of ESR-TEL-JAK2/Cd3e –/– mice (78%; 18 out of 23) also developed external signs of hematological malignancy and invasion of nonlymphoid ... Ambit Biosciences Corporation Presents Phase I Clinical Results of … - Dec 7, 2009 Bizjournals.com..."AML represents a challenging hematological malignancy to treat. A significant portion of AML patients have activating FLT3 mutations, and these patients ... High-dose chemotherapy followed by autologous stem cell … - Oct 15, 2007 Nature.comMultiple myeloma (MM) is the second most frequent hematological malignancy. It is characterized by neoplastic proliferation of a single clone of plasma ... Westmoreland briefs - Jul 2, 2009 Pittsburgh Post-Gazette - Pittsburgh Post Gazette...said the goal of "Teeing off for T" is to honor his father's memory while helping others who are faced with a hematological malignancy. ... Characterization of acute myeloid leukemia with PTPN11 mutation: the ... - Feb 1, 2008 Nature.comAcute myeloid leukemia (AML) is a relentless hematological malignancy characterized by overproduction of hematopoietic precursor cells with impaired ... Leukemia - Induction of Toll-like receptor 2 and 4 expression on CD4+... - Dec 13, 2007 Nature.com...incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. ... Tacrolimus use in adult allogeneic stem cell transplant recipients … - Dec 7, 2009 Nature.comA total of 27 consecutive allogeneic HSCT patients fulfilling the following criteria were studied: hematological malignancy, BU-fludarabine or melphalanCY ... A study to determine the safety profile and maximum tolerated dose of... - May 22, 2006 Nature.comTherapy of deep fungal infection in hematological malignancy. J Antimicrob Chemother 1997; 40: 779–788. | Article | PubMed |. Donnelly JP, De Pauw BE. ... TET2 mutations in myelodysplasia and myeloid malignancies - Jul 1, 2009 Nature.comMyelodysplasia (MDS) is a hematological malignancy characterized by ineffective hematopoiesis and an increased risk of acute myeloid leukemia (AML). ... Oncolytic virotherapy for multiple myeloma using a tumour-specific... - May 29, 2008 Nature.comVesicular stomatitis virus: a potential therapeutic virus for the treatment of hematological malignancy. Hum Gene Ther 2004; 15: 821–831. ... A case of primary lymphoma of the bladder managed with multimodal … - Jul 20, 2007 Nature.comIn the presented case, the diagnosis of primary bladder lymphoma was made after excluding a systemic hematological malignancy. ... Risk factors for invasive aspergillosis in neutropenic patients with ... - Feb 24, 2005 Nature.comThis result is important, since there is a general trend to offer curative treatment for hematological malignancy to patients of increasing age and with ... TURNER. Carolyn . - Mar 30, 2008 Post And Courier - Google News ArchiveMemorials may be made to Hematological Malignancy Profram, Hollings Cancer Center, 86 Lucas Street, Charles ton. SC 29401 Arrangements by HENRY STUHR INC., ... Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic... - Oct 5, 2009 Nature.com...however, long-term immunosuppressive therapy may lead to life-threatening infections or relapse of underlying hematological malignancy. ... Alemtuzumab Appears Promising as First-Line B-Cell Chronic … - Dec 11, 2006 DG News...department of clinical hematology and hematological malignancy diagnostic service, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom. ... Compound heterozygosity for two MSH2 mutations suggests mild … - Dec 4, 2007 Nature.comWhiteside D, McLeod R, Graham G et al: A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple ... Lumbar puncture and subdural hygroma and hematomas in … - Feb 4, 2008 Nature.comSubdural hygromas in hematological malignancy patients are particularly troublesome because of the increased risk of bleeding from thrombocytopenia. ... Cincinnati Children's Researchers Publish Findings on Potential... - Oct 9, 2006 RedOrbit...are now focused on translating these findings into developing new ways to target the protein as a novel approach to treating hematological malignancy." ... Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in... - Nov 28, 2007 Genetic Engineering News - Genetic Engineering News (press release)Multiple myeloma is the second most common hematological malignancy of adults, accounting for 10% of the diagnoses of hematological malignancies in the ... Folinic acid administration following MTX as prophylaxis for GVHD in ... - Jul 14, 2008 Nature.comMucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for hematological malignancy: an overview. ... ImmunoGen, Inc. Announces Presentation at ASH of Encouraging … - Dec 11, 2006 Free with registration - Business Wire - AccessMyLibrary.com...in an abstract (abstract #4548) to the ASH meeting on a second TAP compound, AVE9633, in development for the treatment of a hematological malignancy. ... New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate … - Jun 7, 2009 RedOrbit...hematological malignancies and progression of malignancy in patients with a pre-existing hematological malignancy or myelodysplastic syndrome (MDS). ... Press Release: Research and Markets: Hematological Malignancies - … - May 12, 2005 Pay-Per-View - PR Newswire - HighBeam ResearchOverview of hematological malignancy market including patient segmentation, unmet needs and how novel therapies will alter existing treatment patterns ... Cincinnati Children's Researchers Publish Findings On Potential... - Oct 10, 2006 Medical News Today - Medical News Today (press release)...are now focused on translating these findings into developing new ways to target the protein as a novel approach to treating hematological malignancy." ... Rapid immunodiagnosis of tuberculosis in a woman receiving anti-TNF … - Jan 24, 2007 Nature.com...(2006) Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. Leukemia 20: 379–381 | Article | PubMed ... Geron Presents Interim Clinical Data On Its Telomerase Inhibitor Drug... - Dec 10, 2008 Medical News Today - Medical News Today (press release)Multiple myeloma is the second most common hematological malignancy of adults. The American Cancer Society has projected that 19900 new cases and 10790 ... New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate … - Jun 9, 2009 Medical News Today - Medical News Today (press release)...hematological malignancies and progression of malignancy in patients with a pre-existing hematological malignancy or myelodysplastic syndrome (MDS). ... PDL BioPharma Presents Preclinical Data on Novel Monoclonal Antibody … - Dec 11, 2006 Free with registration - PR Newswire - AccessMyLibrary.comMultiple myeloma is the second most common hematological malignancy in the US, accounting for about 10 percent of all hematologic malignancies and 1 percent ... ImmunoGen, Inc. Files IND for its HuC242-DM4 Targeted Anticancer … - Mar 31, 2005 Free with registration - Business Wire - AccessMyLibrary.com...and - also this spring - we intend to initiate a clinical trial with the compound in multiple myeloma, a hematological malignancy." ... Geron Initiates Clinical Trial of GRN163L in Combination With... - Oct 20, 2008 International Business TimesMultiple myeloma is the second most common hematological malignancy of adults. The American Cancer Society has projected that 19900 new cases and 10790 ... New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate … - Jul 6, 2009 ITNews...hematological malignancies and progression of malignancy in patients with a pre-existing hematological malignancy or myelodysplastic syndrome (MDS). ... Keokuk County Invited To Plow Ahead For A Cure - Jul 27, 2006 zwire.com7 in Council Bluffs, is part of a grassroots campaign called the "Tractor Ride Against Cancer" (TRAC), an effort to support hematological malignancy ... Centennial Medical Center eyes $143M expansion - Oct 26, 2007 Nashville Business JournalIt will have units for bone and marrow transplantation, hematological malignancy, medical oncology and surgical oncology. The center, which will be branded ... Hepatitis B Reactivation Possible After Chemotherapy - Nov 2, 2005 Cancerpage.com...colleagues prospectively followed 46 HBV-positive patients treated with cytotoxic chemotherapy for a hematological malignancy at Queen Mary Hospital. ... A simplified method for stem cell autografting in multiple myeloma: a... - Apr 6, 2009 Nature.com1 It accounts for ~1% of all malignant diseases and is the second most commonly diagnosed hematological malignancy, with an annual incidence in Europe of 23 ... Iowans Invited to Plow Ahead for a Cure - Jul 21, 2006 Wallace's Farmer7 in Council Bluffs , Iowa , is part of a grassroots campaign called the "Tractor Ride Against Cancer" (TRAC), an effort to support hematological malignancy ... Antibiotic Cycling - Mar 1, 2005 Free with registration - Critical Care Alert - AccessMyLibrary.comBecause of the increased incidence of colonization of vancomycin-resistant Enterococcus species (VRE) in hematological malignancy unit, Bradley et al (6) ... Pharmion Corporation at Morgan Stanley Global Healthcare Conference -... - May 2, 2007 Free with registration - Fair Disclosure Wire - AccessMyLibrary.comObviously, the opinion leader population tends to be focused on a given tumor type, much less broadly solid tumor or hematological malignancy. ... Onconova Therapeutics Announces Publication of Positive Phase I … - Oct 28, 2008 Genetic Engineering News - Genetic Engineering News (press release)Na has shown broad-spectrum anti-tumor activity against both solid tumors and hematological malignancy and has demonstrated striking synergistic activity ... Types of Leukemia - May 4, 2007 BuzzleIt is a hematological malignancy. 2. Acute myelogenous leukemia (also known as Acute Myeloid Leukemia or AML) occurs more commonly in adults than in ... Evaluation of several clinical scoring tools in organophosphate... - Mar 1, 2006 Free with registration - Clinical Toxicology - AccessMyLibrary.com...underlying diagnosis (acquired immunodeficiency syndrome, metastatic cancer and hematological malignancy) chosen and weighed by logistic regression. ... ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2005 Financial … - Feb 3, 2005 $4.95 - Business Wire - ECNextImmunoGen also is preparing to initiate a Phase I clinical trial with huN901-DM1 in the treatment of multiple myeloma - a hematological malignancy - and ... Celgene Corp. at Thomas Weisel Partners Healthcare Conference - Part ... - Sep 6, 2006 Free with registration - America's Intelligence Wire - AccessMyLibrary.comWe believe and we certainly hope and have the expectation that Revlimid will be a broad based hematological malignancy therapeutic and we're developing it ... New Phase I Study Announcement Of Interleukin-7 As Immunotherapy In … - Apr 24, 2008 Medical News Today - Medical News Today (press release)Patients admitted to the study must have histologically confirmed non-lymphoid hematological malignancy such as acute myeloid leukemia (AML), ... Lenalidomide is effective and safe oral agent for CLL - Dec 19, 2006 Gerson Lehrman Group...in patients with refractory/relapsed CLL, an indolent B-cell hematological malignancy. The drug was well tolerated in this small study of 45 patients. ... Celgene Corp. at NewsMakers in the Biotech Industry - Final. - Sep 7, 2006 Free with registration - America's Intelligence Wire - AccessMyLibrary.comAnd we're continuing to develop REVLIMID, as we believe it will be a broad-based hematological malignancy therapeutic agent. We're looking at CLL, NHL, ... Celgene Corp. at Leerink Swann Cancer Medicines Conference - Final. - Sep 18, 2006 Free with registration - Fair Disclosure Wire - AccessMyLibrary.comSo we truly believe that Revlimid can be a broad-based hematological malignancy drug. A targeted therapy, as Howard was referring to earlier, that can work ... Cancer survivor rides again - Jul 2, 2008 zwire.com...in a grassroots effort to raise money for hematological malignancy cancer and solid tumor cancer research at the University of Nebraska Medical Center. ... Cytheris Announces New Phase I Study of Interleukin-7 As … - Apr 23, 2008 Genetic Engineering News - Genetic Engineering News (press release)Patients admitted to the study must have histologically confirmed non-lymphoid hematological malignancy such as acute myeloid leukemia (AML), ... WVU Bucks for Brains donations exceed $900,000 - Feb 7, 2009 Huntington Herald DispatchWVU's largest gifts were $630000 for the Osborne Professorship in Hematological Malignancy Research and $168000 for the James H. Walker Chair of Pediatric ... GPC Biotech initiated with "overweight" - Mar 28, 2008 newratings.com...development of GPC Biotech's second lead product, 1D09C3, an antibody for the treatment of hematological malignancy, is likely to begin by Q105. ... Molecular Targets Enhance Chemotherapy in Multiple Myeloma - Apr 14, 2008 newswise.comMM is an incurable cancer of the bone marrow and the second most common hematological malignancy in the United States. To survive, MM cells rely on ... Reevaluation of the National Institutes of Health criteria for... - Nov 16, 2009 Nature.com20 analyzed the clinical feasibility of the new criteria in a study on 110 patients subjected to allo-HCT for a hematological malignancy. ... Onconova Therapeutics Announces Presentation of Clinical and Non- … - Apr 16, 2007 $4.95 - Business Wire - ECNextNa has shown broad-spectrum anti-tumor activity against both solid tumors and hematological malignancy in pre-clinical studies, and has demonstrated ... Policlin San Matteo, Pavia; Thiotepa and fludarabine are well... - Feb 16, 2005 Pay-Per-View - Biotech Week - Factiva, from Dow Jones...major subject areas of Thiotepa, Fludarabine, Reduced Intensity Conditioning Regimen, Allogeneic Stem Cell Transplantation and Hematological Malignancy. ... Hematology; Thiotepa and fludarabine are well-tolerated in hematologic... - Feb 14, 2005 Pay-Per-View - Hematology Week - Factiva, from Dow Jones...major subject areas of Thiotepa, Fludarabine, Reduced Intensity Conditioning Regimen, Allogeneic Stem Cell Transplantation and Hematological Malignancy. ... Multiple Myeloma; Aplidin granted orphan drug status by European … - Jan 1, 2005 Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow JonesMultiple myeloma is the second most common hematological malignancy after non-Hodgkin lymphoma and is part of a spectrum of diseases labeled plasma cell ... Cancer Therapy; IND submitted to US FDA for HuC242-DM4 targeted … - Apr 18, 2005 Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones...and - also this spring - we intend to initiate a clinical trial with the compound in multiple myeloma, a hematological malignancy," Sayare added. ... Cancer Therapy; IND submitted to US FDA for HuC242-DM4 targeted … - Apr 19, 2005 Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones...and - also this spring - we intend to initiate a clinical trial with the compound in multiple myeloma, a hematological malignancy," Sayare added. ... Invasive Fungal Infection; RT panfungal PCR detects early invasive … - Apr 30, 2005 Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow JonesKeywords: Glasgow, Lanark, Scotland, Hematological Malignancy, Stem Cell Transplantation, Invasive Fungal Infection, Real-Time Panfungal PCR, Diagnostics. ... Invasive Fungal Infection; RT panfungal PCR detects early invasive … - Apr 29, 2005 Pay-Per-View - Drug Week - Factiva, from Dow JonesKeywords: Glasgow, Lanark, Scotland, Hematological Malignancy, Stem Cell Transplantation, Invasive Fungal Infection, Real-Time Panfungal PCR, Diagnostics. ... Competitors by Product Report - Mar 29, 2008 $75.00 - Revere Reports - RevereGenzyme Corporation (GENZ) Products:. Genzyme Diagnostics Hematological Malignancy Tests. GeoPharma, Inc. (GORX) Products:. Ovarian Cancer Urine Test ... University of Texas, US Study findings from University of Texas, US,... - Jan 2, 2007 Pay-Per-View - Life Science Weekly - Factiva, from Dow JonesKeywords: Houston, Texas, United States, Antifungal Prophylaxis, Invasive Aspergillosis, Hematological Malignancy, Risk Reduction. ... Competitors by Product Report - Nov 28, 2009 $75.00 - Revere Reports - RevereGenzyme Corporation (GENZ) Products:. Genzyme Diagnostics Hematological Malignancy Tests. GeoPharma, Inc. (GORX) Products:. Ovarian Cancer Urine Test ... Competitors by Product Report - Nov 28, 2009 $75.00 - Revere Reports - RevereGenzyme Corporation (GENZ) Products:. Genzyme Diagnostics Hematological Malignancy Tests. GeoPharma, Inc. (GORX) Products:. Ovarian Cancer Urine Test ... Invasive Fungal Infection; RT panfungal PCR detects early invasive … - Apr 25, 2005 Pay-Per-View - Hematology Week - Factiva, from Dow JonesKeywords: Glasgow, Lanark, Scotland, Hematological Malignancy, Stem Cell Transplantation, Invasive Fungal Infection, Real-Time Panfungal PCR, Diagnostics. ... Invasive Fungal Infection; RT panfungal PCR detects early invasive … - Apr 26, 2005 Pay-Per-View - Cancer Weekly - Factiva, from Dow JonesKeywords: Glasgow, Lanark, Scotland, Hematological Malignancy, Stem Cell Transplantation, Invasive Fungal Infection, Real-Time Panfungal PCR, Diagnostics. ... Background information on Hematological malignancy [When available] Although hematological malignancies are a form of cancer, they are generally treated by specialists in hematology, although in many hospitals oncology specialists also manage these diseases. ("Hematology/Oncology" is a single subspecialty of Internal Medicine; there are also surgical and radiation oncologists.) Hematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. As the three are intimately connected through the immune system, a disease affecting one of the three will often affect the others as well: although lymphoma is technically a disease of the lymph nodes, it often spreads to the bone marrow, affecting the blood and occasionally producing a paraprotein. Chromosomal translocations are a common cause of these diseases, while this is uncommon in solid tumors. This leads to a different approach in diagnosis and treatment of hematological malignancies. Search the web for more resources on Hematological malignancy |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
